wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Pharmacology

Total questions: 92

Worksheet time: 46mins

Name
Class
Date
1.

Products containing moderate amounts of controlled

substances. They may be dispensed by the pharmacist

without a physician’s prescription but with some restrictions

regarding the amount, record keeping, and other safeguards.

Included are antidiarrheal drugs, such as diphenoxylate

a)

Schedule V

b)

Schedule III

c)

Schedule II

d)

Schedule I

2.

Drugs that are not approved for medical use and have high

abuse potentials: heroin, lysergic acid diethylamide (LSD),

a)

Schedule I

b)

Schedule II

c)

Schedule III

d)

Schedule IV

3.

Drugs that are used medically have high abuse potential:

opioid analgesics (eg, codeine, hydromorphone, methadone, meperidine, morphine, oxycodone, oxymorphone), central

nervous system (CNS) stimulants (eg, cocaine, methamphetamine, methylphenidate), and barbiturate

sedative-hypnotics (amobarbital, pentobarbital, secobarbital).

a)

Schedule I

b)

Schedule II

c)

Schedule III

d)

Schedule IV

4.

Drugs that are used medically have high abuse potential:

opioid analgesics (eg, codeine, hydromorphone, methadone, meperidine, morphine, oxycodone, oxymorphone), central

nervous system (CNS) stimulants (eg, cocaine, methamphetamine, methylphenidate), and barbiturate

sedative-hypnotics (amobarbital, pentobarbital, secobarbital).

a)

Schedule I

b)

Schedule II

c)

Schedule III

d)

Schedule IV

5.

Drugs with less potential for abuse than those in Schedules I

and II, but abuse may lead to psychological or physical

dependence: androgens and anabolic steroids, some CNS

stimulants (eg, benzphetamine), and mixtures containing small

amounts of controlled substances (eg, codeine, barbiturates

not listed in other schedules).  Steroids – for muscle mass; harms the immune system

a)

Schedule I

b)

Schedule II

c)

Schedule III

d)

Schedule IV

6.

Drugs with some potential for abuse: benzodiazepines (eg, diazepam, lorazepam, temazepam), other sedative-hypnotics

(eg, phenobarbital, chloral hydrate), and some prescription

appetite suppressants (eg, mazindol, phentermine).

a)

Schedule I

b)

Schedule II

c)

Schedule III

d)

Schedule IV

7.

is related to the chemical or official name and

is independent of the manufacturer

a)

generic name

b)

trade name

c)

unique name

d)

chemical name

8.

is designated and patented by the

manufacturer.

a)

generic name

b)

trade name

c)

unique name

d)

chemical name

9.

is the exact molecular formula of the

drug; usually a long, very difficult name to pronounce and

of a little concern to the health care worker.

a)

generic name

b)

trade name

c)

unique name

d)

chemical name

10.

Pharmakon means?

a)

study

b)

drugs

c)

medicine

d)

Pharmacy

11.

ology comes from logos which means?

a)

study

b)

drugs

c)

medicine

d)

Pharmacy

12.

Branch of medicine concerned with the prevention of disease

and treatment of suffering

a)

therapeutics

b)

pharmacotherapeutics

c)

pharmacognosy

d)

pharmacokinetics

e)

pharmacodynamics

13.

Application of drugs for the purpose of disease prevention and treatment of suffering

a)

therapeutics

b)

pharmacotherapeutics

c)

pharmacognosy

d)

pharmacokinetics

e)

pharmacodynamics

14.

Study of biochemical and physiological effects of drugs; study of drugs mechanism of action.

a)

therapeutics

b)

pharmacotherapeutics

c)

pharmacognosy

d)

pharmacokinetics

e)

pharmacodynamics

15.

How medicine changes the body (alters the cell physiology) - such

changes require that the drug interact with specific molecules and

chemicals normally found in the body

a)

therapeutics

b)

pharmacotherapeutics

c)

pharmacognosy

d)

pharmacokinetics

e)

pharmacodynamics

16.

Study of drug movement throughout the body (how the body

handles the medication)

a)

therapeutics

b)

pharmacotherapeutics

c)

pharmacognosy

d)

pharmacokinetics

e)

pharmacodynamics

17.

Involves absorption (small intestine), distribution, metabolism

(biotransformation), and excretion

a)

therapeutics

b)

pharmacotherapeutics

c)

pharmacognosy

d)

pharmacokinetics

e)

pharmacodynamics

18.

Study of drugs derived from herbal and other natural sources.

a)

therapeutics

b)

naturology

c)

pharmacognosy

d)

pharmacokinetics

e)

toxicology

19.

Study of drugs derived from herbal and other natural sources.

a)

therapeutics

b)

naturology

c)

pharmacognosy

d)

pharmacokinetics

e)

toxicology

20.

Study of poisons and poisoning.

a)

toxinology

b)

naturology

c)

pharmacognosy

d)

pharmacokinetics

e)

toxicology

21.

this is where absorption of drugs happen

a)

small intestine

b)

liver

c)

large intestine

d)

stomach

22.

also known as metabolism

a)

biotransformation

b)

bio transition

c)

both answers are correct

d)

none of the above

23.

also known as movement or motion

a)

static

b)

kinetics

c)

dynamics

d)

potential

24.

also known as change

a)

static

b)

kinetics

c)

dynamics

d)

potential

25.

different sources of drugs except

a)

plants

b)

animals

c)

minerals

d)

synthetic chemicals

e)

vitamins

26.

Are those that have on their labels the prescription legend and can be prescribed by the physicians, dentists, veterinarians, or another legally authorized health practitioner as part of their specific practice

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

27.

ambroxol is a labeled as this kind of drug

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

28.

paracetamol is a labeled as this kind of drug

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

29.

these kinds of drugs may be legally acquired by the patient without the prescription order

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

30.

also known as over-the-counter drugs

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

31.

these kind of drugs must fulfill the FDA requirements to be approved

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

32.

this kind of drug is a new type of drug a manufacturer wants to market

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

33.

this kind of drug is a new type of drug a manufacturer wants to market

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

34.

Are drugs that have been discovered but are not financially

viable and therefore have not been “adopted” by any drug

company.

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

35.

are those which are used and/or

distributed illegally.

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

36.

a.k.a "Street Drugs"

a)

prescription drugs

b)

illegal drugs

c)

investigational drugs

d)

orphan drugs

e)

non-prescription drugs

37.

Adequate studies on pregnant women have NOT

demonstrated a risk in the fetus in the first trimester of

pregnancy and there is no evidence of risk in later

trimester.

a)

Category A

b)

Category B

c)

Category C

d)

Category D

38.

Animal studies have NOT demonstrated a risk for the fetus but there are no adequate studies on pregnant women or animal studies have shown an adverse effect, but adequate studies on pregnant women have not demonstrated a risk to the fetus during the first trimester, and there is no evidence of risk in the third trimester

a)

Category A

b)

Category B

c)

Category C

d)

Category D

39.

the fetus is safe in this category but the mother's safety is uncertain

a)

Category A

b)

Category B

c)

Category C

d)

Category D

40.

Animal studies have shown an adverse effect on the fetus but there are no adequate studies in humans, the benefits from the use of the drug in pregnant women may be acceptable despite the potential risks, or there are no animal reproduction studies and no adequate studies in humans.

a)

Category A

b)

Category B

c)

Category C

d)

Category D

41.

There is evidence of human fetal risk, but the potential benefits

from the use of the drug in pregnant women may be

acceptable despite its potential risks.

a)

Category A

b)

Category B

c)

Category C

d)

Category D

42.

Teratogenic are in this category

a)

Category A

b)

Category B

c)

Category C

d)

Category D

43.

Legally, consumers have _ routes of access to

therapeutic drugs.

a)

one

b)

two

c)

three

d)

four

44.

one route is by ____

a)

prescription and OTC

b)

Probation and UTCS

c)

Prescription and UTC

d)

Transaction and Prescription

45.

is responsible for assuring that new drugs are safe and effective before approving the drugs and allowing them to be marketed.

a)

CDC

b)

ANA

c)

DOH

d)

FDA

46.

the testing process for drugs is usually tested on?

a)

human subjects

b)

animal subjects

c)

both

d)

they're not tested at all

47.

what kind of animal is usually used for drug testing?

a)

albino rats

b)

bunnies

c)

dogs

d)

hamsters

48.

in this phase, a few doses are given to a few healthy

volunteers to determine safe dosages, routes of

administration, absorption, metabolism, excretion, and

toxicity.

a)

Phase 1

b)

Phase 2

c)

Phase 3

d)

Phase 4

49.

a few doses are given to a few subjects with the disease or symptom for which the drug is being studied, and responses are compared with those of healthy subjects

a)

Phase 1

b)

Phase 2

c)

Phase 3

d)

Phase 4

50.

this phase focuses more on the general term

a)

Phase 1

b)

Phase 2

c)

Phase 3

d)

Phase 4

51.

this phase focuses more on the specific term

a)

Phase 1

b)

Phase 2

c)

Phase 3

d)

Phase 4

52.

the drug is given to a larger and more representative group of subjects.

a)

Phase 1

b)

Phase 2

c)

Phase 3

d)

Phase 4

53.

after a drug is approved for marketing, it enters a phase of continual evaluation.

a)

Phase 1

b)

Phase 2

c)

Phase 3

d)

Phase 4

54.

may or may not have a termination date, may be carried out indefinitely

a)

PRN

b)

STAT

c)

Single Order

d)

Standing

55.

In some agencies, it may automatically be canceled after a specific number of days and must be reordered

a)

PRN

b)

STAT

c)

Single Order

d)

Standing

56.

Carried out for one time only or to be given once at a specified time

a)

PRN

b)

STAT

c)

Single Order

d)

Standing

57.

Indicates that the medication is to be given immediately and only once

a)

PRN

b)

STAT

c)

Single Order

d)

Standing

58.

are used in emergency situations like cardiac arrest

a)

PRN

b)

STAT

c)

Single Order

d)

Standing

59.

Carried out as the patient requires

a)

PRN

b)

STAT

c)

Single Order

d)

Standing

60.

permits the nurse to give a medication when in the nurse’s judgment, the client requires it.

a)

PRN

b)

STAT

c)

Single Order

d)

Standing

61.

also known as the “Dangerous Drug Act of 1972”

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

62.

eradicates the use of prohibited drugs and controls the use of narcotic and regulated drugs.

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

63.

also known as the “Comprehensive Dangerous Drug Act of 2002”

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

64.

reveals some provisions of R.A.6425.

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

65.

also known as the “Generics Act of 1988”

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

66.

promotes, requires, and ensures the production of adequate supply, distribution, use, and acceptance of drugs and medicines identified by their generic names

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

67.

also known as the “Special Law on Counterfeit Drugs”

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

68.

prohibits counterfeit drugs and provides penalties for violations

a)

R.A.6425.

b)

R.A.9165.

c)

R.A.6675.

d)

R.A.8203.

69.

The reasons for administering a medication or performing a treatment

a)

indications

b)

contraindications

c)

dose

d)

mechanism of action

70.

A factor that prevents the use of a medication or treatment

(eg. Allergies)

a)

indications

b)

contraindications

c)

dose

d)

mechanism of action

71.

The amount of a drug to be administered at one time

a)

indications

b)

contraindications

c)

dose

d)

mechanism of action

72.

How a drug works

a)

indications

b)

contraindications

c)

dose

d)

mechanism of action

73.

the primary effects intended; desired effect.

a)

therapeutic effect

b)

side effect

c)

adverse effect

d)

drug allergy

e)

cumulative effect

74.

secondary effect; unintended;

a)

therapeutic effect

b)

side effect

c)

adverse effect

d)

drug allergy

e)

cumulative effect

75.

more severe than side effects; undesirable

a)

therapeutic effect

b)

side effect

c)

adverse effect

d)

drug allergy

e)

cumulative effect

76.

immunologic reaction to a drug; skin test first

a)

therapeutic effect

b)

side effect

c)

adverse effect

d)

drug allergy

e)

cumulative effect

77.

severe allergic reaction w/c usually occurs immediately following drug administration; the widespread release of histamine

a)

Anaphylactic reaction

b)

Adverse reaction

c)

Drug Tolerance

d)

Drug allergy

e)

Cumulative effect

78.

decreased physiologic response to the repeated administration of a drug or chemically related substance; plateau

a)

Anaphylactic reaction

b)

Adverse reaction

c)

Drug Tolerance

d)

Drug allergy

e)

Cumulative effect

79.

increasing response to the repeated doses of a drug that occurs when the rate of administration exceeds the rate of metabolism or excretion.

a)

Idiosyncratic effect

b)

Adverse reaction

c)

Drug Tolerance

d)

Drug allergy

e)

Cumulative effect

80.

unexpected response to the drug, either over response, under response, different response than expected, unpredictable or unexplained responses; changing responses to different people

a)

Idiosyncratic effect

b)

Adverse reaction

c)

Drug Tolerance

d)

Drug allergy

e)

Cumulative effect

81.

Inappropriate intake of a substance

a)

Drug abuse

b)

Drug dependance

c)

Drug interaction

d)

Drug allergy

e)

Drug tolerance

82.

illegal use; for you to be “high”

a)

Drug abuse

b)

Drug dependance

c)

Drug interaction

d)

Drug allergy

e)

Drug tolerance

83.

illegal use; for you to be “high”

a)

Drug abuse

b)

Drug dependance

c)

Drug interaction

d)

Drug allergy

e)

Drug tolerance

84.

you feel the urge to satisfy your

physical and physiological needs

a)

Drug abuse

b)

Drug dependance

c)

Drug interaction

d)

Drug allergy

e)

Drug tolerance

85.

person’s reliance or a need to take a drug or substance

a)

Drug abuse

b)

Drug dependance

c)

Drug interaction

d)

Drug allergy

e)

Drug tolerance

86.

Occurs when the administration of one drug before, at the same time as, or after another drug alters the effect of one or both drugs; 20 minutes interval of drug intake

a)

Drug abuse

b)

Drug dependance

c)

Drug interaction

d)

Drug allergy

e)

Drug tolerance

87.

A drug that is more potent will produce a therapeutic effect at a lower dose, compared with another drug in the same class.

a)

intensity

b)

complexity

c)

potency

d)

efficacy

e)

severity

88.

The magnitude of maximal response that can be produced from a particular drug

a)

intensity

b)

complexity

c)

potency

d)

efficacy

e)

severity

89.

the time after administration when the body initially responds

to the drug

a)

DURATION OF ACTION

b)

PLATEAU

c)

PEAK PLASMA LEVEL

d)

ONSET OF ACTION

90.

the highest plasma level achieved by a single dose when the elimination rate of a drug equals the absorption rate

a)

DURATION OF ACTION

b)

PLATEAU

c)

PEAK PLASMA LEVEL

d)

ONSET OF ACTION

91.

a maintained concentration of a drug in the plasma during a series of scheduled doses

a)

DURATION OF ACTION

b)

PLATEAU

c)

PEAK PLASMA LEVEL

d)

ONSET OF ACTION

92.

the length of time the drug produces its therapeutic effect

a)

DURATION OF ACTION

b)

PLATEAU

c)

PEAK PLASMA LEVEL

d)

ONSET OF ACTION